Veriheal

NOVEMBER 6, 2023

The Act aimed to provide patients access to smokable flower for 15 medical conditions. However, the state’s legislative landscape is evolving, with the passage of a bill to fully legalize medical cannabis in 2022. According to a 2022 survey, 54% of Wyoming’s residents endorse cannabis legalization for recreational use.

Legalization 117

Legalization Recreational THC CBD 117

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). 2] David E.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

JUNE 30, 2023

Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin. The basis of the CSMAS argument stems from the findings of the 2022 Summit on Cannabinoids in College Athletics. The Summit found that cannabis does not enhance athletic performance.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

APRIL 14, 2022

pursuant to Drug Enforcement Agency (DEA) or state-level programs). Before legalization, illicit grow sites did not have access to water utilities and were typically grown in arid/remote areas, often depleting local surface water and shallow aquifers not suited to intensive use.

Environment 52

Environment Agriculture Compliance Compliance 52

Veriheal

DECEMBER 27, 2022

In light of this, the Drug Enforcement Administration (DEA) has announced its intention to substantially increase the production quota of psychedelics such as LSD, psilocybin, and mescaline due to be studied in 2023. . ” This defines one’s ability to connect to the natural world and identify nature as an essential part of life.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Canna Law Blog

MARCH 21, 2022

Drug Enforcement Agency (DEA) reported that the federalization of hemp would result in hemp shielding criminal activities. The moratoriums are retroactive and apply to any application receive by the ODA, including applications received on or after January 1, 2022. Specifics of SB 1564 and the Oregon hemp moratoriums.

Hemp 75

Hemp DEA Conditions Agriculture 75

Cannabis Law Report

JULY 28, 2022

July 28, 2022. Colorado could decriminalize the personal use and possession of certain psychedelic plants and fungi, including “magic mushrooms,” and create a Natural Medicine Access Program, according to a voter initiative on the November ballot. By Dan Flynn. Petitioners had six months to circulate signature petitions.

Legalization 52

Legalization Decriminalization Food Safety 52

The Blunt Truth

JANUARY 16, 2020

Pretty much every news outlet that covers cannabis has a piece on this, Marijuana Business Daily has a nice round-up that’s free to access. The DEA is moving to offer proposed regulations for researchers who want to grow cannabis; the regulations are currently under review by the Office of Management and Budget.

Decriminalization 60

Decriminalization DEA Hemp Legislation 60

Cannabis Law Report

MAY 31, 2022

The only opportunity to currently participate would be through an active clinical trial or via an argument under the Right to Try Act of 2018 (an act which provides a pathway for patients with life-threatening diseases or conditions to access unapproved treatments). 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

DECEMBER 15, 2021

The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). “Having a supply partner that gives us access to the rapidly growing U.S.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Veriheal

AUGUST 24, 2022

In a statement to The Denver Post, Natural Medicine Colorado—which sponsored the act—said “the measure is designed to prioritize mental health and healing, while balancing safety and access.” ” The spokesperson added, “Those are the sole motivations for the design of the initiative.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . April 5, 2022. 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Canna Law Blog

MAY 1, 2024

I take issue with some of the headlines , so here’s mine: “DEA Reportedly Agrees to Initiate Proposed Rulemaking to Reschedule Marijuana…”. In October of 2022, President Biden requested that the Department of Health and Human Services (HHS) review marijuana’s placement on Schedule I of the Controlled Substances Act (CSA).

DEA 82

DEA Marijuana Business Banking 82

Cannabis Law Report

FEBRUARY 28, 2022

20 February 2022. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 1669, 1670 (2021) (arguing that patents on psychedelics may limit research, innovation, and public access). Essay by I. Glenn Cohen & Mason Marks. war on drugs.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105

Vaping Research and Development Data Business 105

Americans for Safe Access

AUGUST 31, 2023

Their findings were sent to the Drug Enforcement Administration (DEA) who will be performing the final review for the Department of Justice (DOJ) in response to President Biden’s request in October 2022 for HHS and DOJ to look into the scheduling of cannabis.

Policy 251

Policy DEA Food Cannabis 251

Canna Law Blog

NOVEMBER 3, 2023

They would get similar access to banking, SBA loans, and federal tax treatment, for starters. I do foresee potential issues with access to trademarks and bankruptcy — which no one seems to be talking much about — but those are topics for another day. My secondary hope is that the litigation somehow compels Congress to act.

Topical 112

Topical DEA Cannabis State Laws 112

Cannabis Law Report

APRIL 13, 2022

Apr 12, 2022, 07:00 ET. Transaction expected to close in June 2022 , following anticipated shareholder approval. market presence, complementary client programming and respected clinical research capabilities allow us to accelerate our strategic growth plans and broaden access to healing and wellness.” NEWS PROVIDED BY.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping. Webcast Information.

Data 95

Data Vaping Supply Chain Business 95

Project CBD

AUGUST 23, 2023

Marketing to Minors Unlike state-regulated cannabis, this new wave of acutely intoxicating substances is easily accessible to minors. There must be a concerted effort by the FDA and DEA to address the public health crisis spawned by the proliferation of unregulated designer drugs being sold under the guise of hemp.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Canna Law Blog

JULY 25, 2020

FDA and DEA in describing its reasoning for this position. Other legislators such as Panfilo Lacson and Aquilino Pimentel III have also weighed into the discussion regarding whether a medical cannabis act is necessary or the most beneficial way for the Filipino people to access cannabis and cannabis-derived medical products.

Supply Chain 98

Supply Chain DEA Legislation Hemp 98

The Cannigma

MAY 15, 2023

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. The post How to access and assess ketamine therapy options appeared first on The Cannigma.

Therapy 78

Therapy Access Blood Pressure Treatment 78

SpeedWeed

JULY 17, 2021

Legal weed businesses would be able to open bank accounts, access loans, or list on the US stock market. If passed, the bill would transfer most of the regulatory authority over cannabis from the Drug Enforcement Administration (DEA) to the Food and Drug Administration (FDA).

Legalization 52

Legalization Collective Hash Legislation 52

Sensi Seeds

NOVEMBER 28, 2018

Food and Drug Administration (FDA) earlier this year, and convince the DEA to reclassify CBD from a Schedule I (most restrictive category) to a Schedule V drug (least restrictive category.) CBD market at a staggering $22 billion by 2022. CBD Regulation is Needed.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

Review our compilation of cannabis trends for 2022 to stay up to date on the latest news in the cannabis industry and ensure you are prepared for the future. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

The Blunt Truth

FEBRUARY 10, 2022

This makes the sixth time the House has passed a provision allowing cannabis businesses to access the federal banking system. The Hemp Advancement Act of 2022 would allow hemp to contain 1% THC, up from 0.3% The bill would also permit non-DEA labs to test the crop for THC, and would count delta-8 in allowable THC amounts.

Hemp 111

Hemp DEA THC Banking 111

The Cannigma

FEBRUARY 16, 2022

So, with that, we should get into it, but don’t forget to check out our segment with Americans for Safe Access. We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. billion made in two years, just two years from January 2020 to January 2022. Let’s listen to Steven.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

APRIL 4, 2022

Congress, signed into law by President Trump, with 41 state enactments, give terminally ill patients access to experimental medicines still in development? But the Drug Enforcement Agency is barring access to one such experimental medicine: psilocybin, also known in its fungal form as “magic mushrooms.”. Read more at.

Access 52

Access Patients DEA Research and Development 52

The Blunt Truth

JANUARY 19, 2024

HHS DOCUMENT RELEASE Last month , the Department of Health and Human Services (HHS) released a heavily redacted version of their recommendation to the Drug Enforcement Administration (DEA) that cannabis be moved from Schedule I to Schedule III. Of course, the DEA will make its own decision, as we noted earlier this month.

DEA 59

DEA Retail Consumption Legalization 59

NewsMunchies

DECEMBER 22, 2021

As of this writing, cannabis remains a prohibited Schedule 1 drug, defined by the DEA as having “no currently accepted medical use and a high potential for abuse.” . Most Americans have access to either medical or adult-use cannabis under state laws. Although, marijuana may be one of the truly bipartisan issues in the U.S.

Law 89

Law Marijuana DEA Legalization 89

Cannabis Law Report

JUNE 25, 2021

Drug Enforcement Agency (DEA)’s narcotic drug schedule as defined by the Controlled Substances Act (CSA). As mentioned before, banks want to avoid risk as much as possible, so ensuring that your site is designed with accuracy and proper access in mind could help assuage concerns.

Banking 66

Banking CBD Hemp Seed-To-Sale 66

Cannabis Law Report

AUGUST 5, 2021

Schumer’s proposal (keep in mind that he is up for reelection in 2022) includes five key pillars: Federally deschedule cannabis- The Attorney General would have 60 days to formalize this and treat cannabis as a dietary supplement with the ability to make claims like other supplements. Key Elements of Proposal. How to regulate synthetic THC.

Banking 111

Banking Vaping Education DEA 111